Home » Case Studies » Value Access and Pricing » Orphan Drug Access and Funding

Orphan Drug Access and Funding

CBPartners recently developed a strategy playbook and overall approach to achieving orphan drug access and funding across CEE markets.

Objectives

To provide insights into the orphan disease therapy pricing and market access (P&MA) landscape across Central and Eastern Europe (CEE), and develop an overall approach to achieving access for orphan drug portfolio based on market archetypes.

Scope

Methodology

Provide an overview of regional archetypes and time-dependent pathways for orphan drug coverage, identify commercial opportunities to accelerate growth and funding as well as a country deep dive to advise local access plans for the client.

Objectives

  • Analogue assessment to determine specific orphan drug access examples to reference.
  • Regional orphan drug funding market archetypes.
  • Local access plans based on market deep dive analysis.
  • Final strategy playbook and overall recommendations

Illustrative Outputs

Impact

CBP developed an overall approach to achieving orphan drug access with guidance for orphan funding options in select CEE markets.